Vimarsana
Biggest News Aggregation in the World

Multiple Sclerosis Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Drug Today - Breaking & Trending Today

Global Multiple Sclerosis Treatment Market Report 2023: - Vimarsana News

Global Multiple Sclerosis Treatment Market Report 2023:

Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ...

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics - Vimarsana News

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics

Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.

Novartis wins US court appeal after challenge to Gilenya patent - Vimarsana News

Novartis wins US court appeal after challenge to Gilenya patent

This decision confirms the validity of the Gilenya patent and allows that injunction to remain in place, Novartis said